News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BaroFold, Inc. CEO to Chair Panel Regarding Biologics and Drug Development Challenges: 'Novel Approaches to Protein Aggregation and Production' at the Biotechnology Industry Organization (BIO) International Conference


5/7/2007 2:25:41 PM

BOULDER, Colo.--(BUSINESS WIRE)--BaroFold, Inc. announced today that Dr. Lyndal Hesterberg, President and CEO, will be chairing the panel discussion as part of the Biologics and Drug Development Challenges section: “Novel Approaches to Protein Aggregation and Production” at the Biotechnology Industry Organization’s International Convention.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES